Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days ...
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPDU.S. patent to expire in March 2043, including 1,095 days of Patent Term AdjustmentNotice of allowance also recei ...
Researchers at the Oak Ridge National Laboratory National Transportation Research Center have designed a ...
CS2009 was designed to restore T-cell effector function, remodel the tumor microenvironment (TME), and enhance T-cell priming via simultaneous targeting of PD-1, VEGF, and CTLA-4, aiming to generate ...
The appointment follows NewcelX's recently announced successful FDA Type B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials ...
Next-gen comms platforms are shifting from FPGAs to ASIC-based architectures. How does custom silicon deliver major gains in ...
A research team led by Professor Il-Joo Cho of Korea University College of Medicine has developed a novel brain implant ...
Controlling light within microscopic spaces is crucial for next-generation optical devices such as photonic integrated ...
A newly developed material can control and "program" heat, allowing it to direct thermal radiation, switch modes, and ...
Celldetective is an open-source software integrating segmentation, tracking, and event detection to perform high-throughput end-to-end study of dynamic cell interactions, without requiring coding ...